Overview: Leptospira Qualitative PCR TestIntroduction: The Leptospira Qualitative PCR Test detects Leptospira DNA to diagnose leptospirosis, causing fever or kidney issues. Aligned with 2023 WHO guidelines, it uses PCR for high specificity, supporting parasite screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in parasitology for patients with suspected leptospirosis.
Other Names: Leptospira PCR Assay, Leptospirosis DNA Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: Leptospira PCR testing began in the 1990s with infectious disease research. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Leptospira DNA to diagnose leptospirosis, guides treatment, and evaluates patients with fever or kidney issues.
Test Parameters: 1. Leptospira DNA
Pretest Condition: No fasting required. Collect whole blood, serum, plasma, urine, CSF, or saliva. Report history of fever, kidney issues, or exposure to contaminated water.
Specimen: Whole Blood (EDTA, 2-5 mL), Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), Urine (sterile container, 5-20 mL), CSF (sterile container, 1-2 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, kidney issues, jaundice, or exposure to contaminated water or animals. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, leptospirosis implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect Leptospira DNA in various specimens. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for leptospirosis diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or contamination can affect results. Low DNA yield may reduce sensitivity.
Clinical Significance: Positive Leptospira DNA confirms leptospirosis, guiding antibiotic therapy. Negative results may require serology or further testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Leptospira IgM, IgG test, or blood-culture to confirm leptospirosis diagnosis.
Test Limitations: Early infection may yield false negatives; clinical correlation is needed. Sample quality affects sensitivity.
References: WHO Leptospirosis Guidelines, 2023; Clinical Infectious Diseases, Levett PN, 2022.
